CAS No.
[18771-50-1(Unlabeled)]
Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Tetrahydro Uridine-d3, 18771-50-1(Unlabeled)
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 95 %
Hazard Compound
No -Refer MSDS for accurate information
Tetrahydro Uridine-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Tetrahydro Uridine-d3 usage and description
Tetrahydro uridine D3 (THU-D3) is a modified version of the nucleoside uridine, which is found naturally in RNA and plays a crucial role in the synthesis of new RNA molecules. THU-D3 is a synthetic analog that has been modified to enhance its bioavailability and stability, and is commonly used in research and pharmaceutical applications.
THU-D3 has been shown to have a wide range of potential therapeutic applications, including in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as in the treatment of mood disorders and cognitive dysfunction. It is believed to work by increasing the levels of uridine in the brain, which in turn can enhance the function of neurotransmitters and improve cognitive processes such as memory and learning.
Chemically, THU-D3 is a pyrimidine nucleoside that consists of a nitrogenous base (uracil) attached to a ribose sugar molecule. The addition of four hydrogen atoms to the uracil molecule creates the "tetrahydro" form of uridine, which is more stable and bioavailable than the natural form. D3 refers to the deuterium atoms that have been added to the molecule, which can enhance its stability and pharmacokinetic properties.
In summary, THU-D3 is a modified version of uridine that has potential therapeutic applications in the treatment of multiple neurological and cognitive disorders. Its chemical modifications enhance its stability and bioavailability, making it a useful tool for researchers and pharmaceutical developers.
